Tuesday, June 23, 2026

JW Pharmaceuticals Secures Exclusive Rights for Innovative GLP-1 Drug Vopaglutide in South Korea

JW Pharmaceutical secures exclusive rights for Vopaglutide, a promising treatment for diabetes and obesity, with significant milestone payments.

North Korea’s Anti-U.S. Rheteorics Grows ahead of U.S. Presidential Election

Kim has labeled the U.S. a "hostile state" that they will contend with for generations ahead of the upcoming U.S. election in November.

How Wonju’s 150 Billion KRW AI Aesthetic Medical Device Project Will Transform the Beauty Sector by 2030

Wonju City plans to invest 20 billion KRW to enhance its beauty and medical device industries, focusing on AI integration by 2030.

Tag: Eurasian Charter

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.